XML 29 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
September 2025 private placement
Common Warrants
Preferred Stock
Series A Preferred Stock
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
February 2025 private placement
Common Stock
Class A Common Stock
September 2025 private placement
Common Stock
Class A Common Stock
Pre Funded Warrants
Common Stock
Class A Common Stock
Common Warrants
Common Stock
Class A Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
September 2025 private placement
Additional Paid-in Capital
Common Warrants
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023       167,972 1,940,899                    
Beginning balance at Dec. 31, 2023 $ 16,751     $ 0 $ 1           $ 119,724     $ 1,301 $ (104,275)
Shares issued for:                              
Vesting of restricted share units (in shares)         27,564                    
Stock compensation 959                   959        
Foreign currency translation 1,412                         1,412  
Fixed dividends Preferred Series B (952)                   (952)        
Net loss (11,628)                           (11,628)
Ending balance (in shares) at Sep. 30, 2024       167,972 1,968,463                    
Ending balance at Sep. 30, 2024 6,542     $ 0 $ 1           119,731     2,713 (115,903)
Beginning balance (in shares) at Jun. 30, 2024       167,972 1,963,575                    
Beginning balance at Jun. 30, 2024 7,484     $ 0 $ 1           119,882     443 (112,842)
Shares issued for:                              
Vesting of restricted share units (in shares)         4,888                    
Stock compensation 166                   166        
Foreign currency translation 2,270                         2,270  
Fixed dividends Preferred Series B (317)                   (317)        
Net loss (3,061)                           (3,061)
Ending balance (in shares) at Sep. 30, 2024       167,972 1,968,463                    
Ending balance at Sep. 30, 2024 6,542     $ 0 $ 1           119,731     2,713 (115,903)
Beginning balance (in shares) at Dec. 31, 2024       167,972 1,970,615         (2,199)          
Beginning balance at Dec. 31, 2024 (12,896)     $ 0 $ 0           119,487     227 (132,610)
Shares issued for:                              
Warrants exercised (in shares)               1,063,000 882,000            
Warrants exercised     $ 1,879                   $ 1,879    
Vesting of restricted share units (in shares)         5,537                    
Vesting of restricted share units (3)                   (3)        
Reverse stock split fractional adjustment (in shares)         33                    
Private placement (in shares)           260,000 1,333,333                
Private placement   $ 3,587                   $ 3,587      
Stock compensation 209                   209        
Warrant reclassification from liabilities 2,002                   2,002        
Foreign currency translation 856                         856  
Fixed dividends Preferred Series B (951)                   (951)        
Net loss (14,146)                           (14,146)
Ending balance (in shares) at Sep. 30, 2025       167,972 5,512,319                    
Ending balance at Sep. 30, 2025 (19,463)     $ 0 $ 0           126,210     1,083 (146,756)
Beginning balance (in shares) at Jun. 30, 2025       167,972 2,649,936         (2,199)          
Beginning balance at Jun. 30, 2025 (20,629)     $ 0 $ 0           118,994     949 (140,572)
Shares issued for:                              
Warrants exercised (in shares)               647,500 882,000            
Warrants exercised     $ 1,879                   $ 1,879    
Vesting of restricted share units (in shares)         1,749                    
Private placement (in shares)             1,333,333                
Private placement   $ 3,587                   $ 3,587      
Stock compensation 65                   65        
Foreign currency translation 134                         134  
Fixed dividends Preferred Series B (317)                   (317)        
Net loss (6,184)                           (6,184)
Ending balance (in shares) at Sep. 30, 2025       167,972 5,512,319                    
Ending balance at Sep. 30, 2025 $ (19,463)     $ 0 $ 0           $ 126,210     $ 1,083 $ (146,756)